L. Castellani et al., MAINTENANCE OF THE DIFFERENTIATED STATE IN SKELETAL-MUSCLE - ACTIVATION OF V-SRC DISRUPTS SARCOMERES IN QUAIL MYOTUBES, The Journal of cell biology, 130(4), 1995, pp. 871-885
We have used quail skeletal myotubes expressing a temperature-sensitiv
e allele of the v-src oncogene to address the issue of the homeostasis
of sarcomeric myofibrils in differentiated muscle cells. Reactivation
of the v-Src tyrosine kinase by shifting the cultures to the permissi
ve temperature leads within minutes to the formation of F-actin-contai
ning bodies (ABs), that originate in the ventral region of the myotube
s and increase in number concomitantly with the dismantling of the I-Z
-I complex of the sarcomeres. This process is detailed by confocal and
electron microscopy. Indirect immunofluorescence reveals that ABs con
tain muscle-specific protein isoforms associated with the I-Z-I comple
xes and vinculin, a component of the cytoskeletal network. Anti-phosph
o tyro sine antibodies label proteins in ABs and Z-discs. Evidence is
presented indicating that this phenomenon specifically depends on the
persistent activation of v-Src, rather than on a general increase in p
hosphotyrosine content such as that induced by vanadate. AB formation
is prevented by activation of protein kinase C by phorbol ester or by
treatment with the kinase inhibitor 2-aminopurine, without any detecta
ble effect on tyrosine phosphorylation. Taken together these findings
indicate that phosphorylation of specific target proteins by v-Src, al
though necessary, is not sufficient per se to induce AB formation. In
addition, the signal transduction cascade that culminates in MAP kinas
e activation and its nuclear translocation is activated both by v-Src
and phorbol ester, and is relatively unaffected by 2-aminopurine. Thes
e findings imply that both phorbol esters and 2-aminopurine operate, a
t least in part, at the level of alternative pathways that may diverge
upstream of the MAP kinase and are presumably mediating the early eff
ects of v-Src on the differentiated phenotype.